Oral lichen planus: progress in understanding its malignant potential and the implications for clinical management
Tóm tắt
Từ khóa
Tài liệu tham khảo
Eisen, 1993, The therapy of oral lichen planus, Crit Rev Oral Biol Med, 4, 141, 10.1177/10454411930040020101
Pindborg JJ, Reichart PA, Smith CJ, Sobin LH. WHO International Histological Classification of Tumors: Histological Typing of Cancer and Precancer of the Oral Mucosa. Berlin: Springer; 1997
Miller, 2001, Changing oral care needs in the United States, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 91, 34, 10.1067/moe.2001.110439
Silverman, 1985, A prospective follow-up study of 570 patients with oral lichen planus, Oral Surg Oral Med Oral Pathol, 60, 30, 10.1016/0030-4220(85)90210-5
Gorsky, 1996, Clinical characteristics and treatment of patients with oral lichen planus in Israel, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 82, 644, 10.1016/S1079-2104(96)80439-2
van der Meij, 1999, Interobserver and intraobserver variability in the histology assessment of oral lichen planus, J Oral Pathol Med, 28, 274, 10.1111/j.1600-0714.1999.tb02038.x
Krutchkoff, 1985, Lichenoid dysplasia, Oral Surg Oral Med Oral Pathol, 30, 308, 10.1016/0030-4220(85)90315-9
Urbizo-Velez, 1990, Comparative histopathological studies in oral lichen planus, Acta Morphol Hung, 38, 71
De Jong, 1984, Epithelial dysplasia in oral lichen planus, Int J Oral Surg, 13, 221, 10.1016/S0300-9785(84)80007-1
Silverman, 1991, A prospective study of findings and management in 214 patients with oral lichen planus, Oral Surg Oral Med Oral Pathol, 72, 665, 10.1016/0030-4220(91)90007-Y
Barnard, 1993, Oral cancer development in patients with oral lichen planus, J Oral Pathol Med, 22, 421, 10.1111/j.1600-0714.1993.tb00134.x
Silverman, 1997, Oral lichen planus update, Am J Dent, 10, 259
van der Meij, 1999, A review of the recent literature regarding malignant transformation of oral lichen planus, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 88, 307, 10.1016/S1079-2104(99)70033-8
Hietanen, 1999, A retrospective study of oral lichen planus patients with concurrent or subsequent development of malignancy, Oral Oncol, 35, 278, 10.1016/S1368-8375(98)00116-X
Zhang, 2001, Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia, Oral Oncol, 37, 505, 10.1016/S1368-8375(00)00140-8
Zhang, 2001, Increased genetic damage in oral leukoplakia from high risk sites, Cancer, 91, 2148, 10.1002/1097-0142(20010601)91:11<2148::AID-CNCR1243>3.0.CO;2-G
Rosin, 2000, Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia, Clin Cancer Res, 6, 357
Mao, 1996, Frequent microsatellite alterations at chromosome 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment, Nat Med, 2, 682, 10.1038/nm0696-682
Partridge, 2000, A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization, Cancer Res, 60, 3893
Lee, 2000, Predicting cancer development in oral leukoplakia, Clin Cancer Res, 6, 1702
Zhang, 1999, Local tumor recurrence or emergence of a new primary lesion? A molecular analysis, J Oral Pathol Med, 28, 381, 10.1111/j.1600-0714.1999.tb02058.x
Califano, 2000, Genetic progression and clonal relationship of recurrent premalignant head and neck lesions, Clin Cancer Res, 6, 347
Cairns, 1999, Molecular methods for the diagnosis of cancer, Biochim Biophys Acta, 1423, C11
Ahrendt, 1999, The potential of molecular screening, Surg Oncol Clin N Am, 8, 641, 10.1016/S1055-3207(18)30180-7
Mao, 2000, Can molecular assessment improve classification of head and neck premalignancy?, Clin Cancer Res, 6, 321
Brennan, 1995, Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck, N Engl J Med, 332, 429, 10.1056/NEJM199502163320704
Guo, 2001, Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy, Clin Cancer Res, 7, 1963
Schoelch, 1999, Laser management of oral leukoplakias, Laryngoscope, 109, 949, 10.1097/00005537-199906000-00021
Beenken, 1999, Transforming growth factor alpha (TGF-alpha) expression in dysplastic oral leukoplakia, Head Neck, 21, 566, 10.1002/(SICI)1097-0347(199909)21:6<566::AID-HED11>3.0.CO;2-H
Sudbo, 2001, DNA content as a prognostic marker in patients with oral leukoplakia, N Engl J Med, 44, 1270, 10.1056/NEJM200104263441702
Scully, 2000, Genetic aberrations in oral or head and neck squamous cell carcinoma 3, Oral Oncol, 36, 404, 10.1016/S1368-8375(00)00023-3
Scully, 2000, Genetic aberrations in oral or head and neck squamous cell carcinoma 2, Oral Oncol, 36, 311, 10.1016/S1368-8375(00)00021-X
Scully, 2000, Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN), Oral Oncol, 36, 256, 10.1016/S1368-8375(00)00007-5
Zhang, 1997, Molecular analysis of oral lichen planus. A premalignant lesion?, Am J Pathol, 151, 323
Zhang, 2000, High frequency of allelic loss in dysplastic lichenoid lesions, Lab Invest, 80, 233, 10.1038/labinvest.3780026
Kim, 2001, Evaluation of premalignant potential in oral lichen planus using interphase cytogenetics, J Oral Pathol Med, 30, 65, 10.1034/j.1600-0714.2001.300201.x
Mignogna, 2001, Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus, Oral Oncol, 37, 262, 10.1016/S1368-8375(00)00096-8
Onofre, 2001, Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 91, 535, 10.1067/moe.2001.112949
Epstein, 1997, The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 83, 537, 10.1016/S1079-2104(97)90117-7
Epstein, 1992, Toluidine blue and Lugol’s iodine application in the assessment of oral malignant disease and lesions at risk of malignancy, J Oral Pathol Med, 21, 160, 10.1111/j.1600-0714.1992.tb00094.x
Rosenberg, 1989, Use of meta-analysis to evaluate tolonium chloride in oral cancer screening, Oral Surg Oral Med Oral Pathol, 67, 621, 10.1016/0030-4220(89)90286-7
Warnakulasuriya, 1996, Sensitivity and specificity of OraScan toluidine blue mouthrinse in the detection of oral cancer and precancer, J Oral Pathol Med, 25, 97, 10.1111/j.1600-0714.1996.tb00201.x
Martin, 1998, The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 85, 444, 10.1016/S1079-2104(98)90071-3
Pizer, 1979, An assessment of toluidine blue for the diagnosis of lip lesions, Va Med, 106, 860
Mashberg, 1995, Early detection, diagnosis, and management of oral and oropharyngeal cancer, CA Cancer J Clin, 45, 328, 10.3322/canjclin.45.6.328
Portugal, 1996, The role of toluidine blue in assessing margin status after resection of squamous cell carcinomas of the upper aerodigestive tract, Arch Otolaryngol Head Neck Surg, 122, 517, 10.1001/archotol.1996.01890170051010
Kerawala, 2000, The role of vital tissue staining in the marginal control of oral squamous cell carcinoma, Int J Oral Maxillofac Surg, 29, 32, 10.1016/S0901-5027(00)80121-6
Sciubba, 1999, Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group, J Am Dent Assoc, 130, 1445, 10.14219/jada.archive.1999.0055
Rosin, 1997, The use of exfoliative cell samples to map clonal genetic alterations in the oral epithelium of high-risk patients, Cancer Res, 57, 5258
Demitsu, 2000, Corticosteroid-resistant erosive oral lichen planus successfully treated with topical cyclosporine therapy, Int J Dermatol, 39, 79, 10.1046/j.1365-4362.2000.00863.x
Epstein, 2001, Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 91, 56, 10.1067/moe.2001.111130
Epstein, 1996, Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions, Oral Surg Oral Med Oral Pathol, 82, 532, 10.1016/S1079-2104(96)80198-3
Nousari, 1999, Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil, Arch Dermatol, 135, 1420, 10.1001/archderm.135.11.1420
Popovsky, 2000, New and emerging therapies for diseases of the oral cavity, Dermatol Clin, 18, 113, 10.1016/S0733-8635(05)70152-2
Zouboulis, 2001, Retinoids—which dermatological indications will benefit in the future?, Skin Pharmacol Appl Skin Physiol, 14, 303, 10.1159/000056361
Buajeeb, 1997, Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 83, 21, 10.1016/S1079-2104(97)90085-8
Epstein, 1999, Topical application of vitamin A to oral leukoplakia, Cancer, 86, 921, 10.1002/(SICI)1097-0142(19990915)86:6<921::AID-CNCR5>3.0.CO;2-6
Epstein, 1998, Topical bleomycin for the treatment of dysplastic oral leukoplakia, Cancer, 83, 629, 10.1002/(SICI)1097-0142(19980815)83:4<629::AID-CNCR1>3.0.CO;2-F
Epstein, 1997, Assessing the patient at risk for oral squamous cell carcinoma, Spec Care Dentist, 17, 120, 10.1111/j.1754-4505.1997.tb00881.x
Femiano, 2001, Oral proliferative verrucous leukoplakia (PVL); open trial of surgery compared with combined therapy using surgery and methisoprinol in papillomavirus-related PVL, Int J Oral Maxillofac Surg, 30, 318, 10.1054/ijom.2001.0066
Saito, 2001, Development of squamous cell carcinoma from pre-existent oral leukoplakia, Int J Oral Maxillofac Surg, 30, 49, 10.1054/ijom.2000.0012
Leunig, 2000, Initial experience in the treatment of oral leukoplakia with high-dose vitamin A and follow-up 5-aminolevulinic acid induced protoporphyrin IX fluorescence, Eur Arch Otorhinolaryngol, 257, 327, 10.1007/s004059900222
Hyde, 1999, Oral cancer, Practitioner, 243, 753
Gooris, 1999, Carbon dioxide laser evaporation of leukoplakia of the lower lip, Oral Oncol, 35, 490, 10.1016/S1368-8375(99)00022-6
Tete, 1999, The role of apoptosis and bcl-2 protein in topical treatment of oral leukoplakia with isotretinoin, Minerva Stomatol, 48, 411
Piattelli, 1999, bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia, Oral Oncol, 35, 314, 10.1016/S1368-8375(98)00095-5
Garewal, 1999, Beta-carotene produces sustained remissions in patients with oral leukoplakia, Arch Otolaryngol Head Neck Surg, 125, 1305, 10.1001/archotol.125.12.1305
Kubler, 1998, Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid, Int J Oral Maxillofac Surg, 27, 466, 10.1016/S0901-5027(98)80040-4
Khafif, 1998, Green tea regulates cell cycle progression in oral leukoplakia, Head Neck, 20, 528, 10.1002/(SICI)1097-0347(199809)20:6<528::AID-HED7>3.0.CO;2-3
Gorsky M, Epstein JB. The effect of retinoids on oral premalignant lesions. Focus on topical therapy. Cancer accepted 2002
Garcia-Pola VJM, Garcia MJM, Gonzales GM, Tenentk AP. Precancerous lesions (oral leukoplakia and lichen planus). Atençion Primera 1998;20:41-4